UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

Definitive Chemoradiation Therapy With Docetaxel, Cisplatin, and 5-Fluorouracil (DCF-R) in Advanced Esophageal Cancer: A Phase 2 Trial (KDOG 0501-P2)

International journal of radiation oncology, biology, physics, 2014-07, Vol.89 (4), p.872-879

2014

Volltextzugriff (PDF)

Prognostic impact of venous invasion in stage IB node-negative gastric cancer

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2015-04, Vol.18 (2), p.297-305

2015

Volltextzugriff (PDF)

Prognostic Advantage of Docetaxel/Cisplatin/ 5-Fluorouracil Neoadjuvant Chemotherapy in Clinical Stage II/III Esophageal Squamous Cell Carcinoma due to Excellent Control of Preoperative Disease and Postoperative Lymph Node Recurrence

Oncology, 2017-01, Vol.92 (4), p.221-228

2017

Volltextzugriff (PDF)

Survival outcome of laparoscopic gastrectomy for clinical early (cT1) gastric cancer

Surgery today (Tokyo, Japan), 2013-09, Vol.43 (9), p.1013-1018

2013

Volltextzugriff (PDF)

Conversion surgery after combination chemotherapy of docetaxel, cisplatin and S-1 (DCS) for far-advanced gastric cancer

Surgery today (Tokyo, Japan), 2017-10, Vol.47 (10), p.1249-1258

2017

Volltextzugriff (PDF)

Long-term prognostic outcome of cT1 gastric cancer patients who underwent laparoscopic gastrectomy after 5-year follow-up

Langenbeck's archives of surgery, 2016-05, Vol.401 (3), p.333-339

2016

Volltextzugriff (PDF)

Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer

BMC cancer, 2011-04, Vol.11 (1), p.122-122, Article 122

2011

Volltextzugriff (PDF)

Lymph node ratio is a critical prognostic predictor in gastric cancer treated with S-1 chemotherapy

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2014, Vol.17 (1), p.67-75

2014

Volltextzugriff (PDF)

Lymphatic Tumor Emboli Detected by D2-40 Immunostaining Can More Accurately Predict Lymph-node Metastasis

World journal of surgery, 2011-09, Vol.35 (9), p.2031-2037

2011

Volltextzugriff (PDF)

Preoperative tumor size is a critical prognostic factor for patients with Borrmann type III gastric cancer

Surgery today (Tokyo, Japan), 2015-01, Vol.45 (1), p.68-77

2015

Volltextzugriff (PDF)

Clinical Significance of Total Gastrectomy for Proximal Gastric Cancer

Anticancer research, 2008-09, Vol.28 (5B), p.2875-2883

2008

Volltextzugriff (PDF)

A Multi-institutional, Prospective, Phase II Feasibility Study of Laparoscopy-Assisted Distal Gastrectomy with D2 Lymph Node Dissection for Locally Advanced Gastric Cancer (JLSSG0901)

World journal of surgery, 2015-11, Vol.39 (11), p.2734-2741

2015

Volltextzugriff (PDF)

Surgical Resection of Stage IV Gastric Cancer and Prognosis

Anticancer research, 2007-11, Vol.27 (6C), p.4381-4386

2007

Volltextzugriff (PDF)

Survival after surgical treatment of early gastric cancer: surgical techniques and long-term survival

Langenbeck's archives of surgery, 2004-04, Vol.389 (2), p.69-74

2004

Volltextzugriff (PDF)

Laparoscopy-assisted pancreas- and spleen-preserving total gastrectomy for gastric cancer as compared with open total gastrectomy

Surgical endoscopy, 2009-11, Vol.23 (11), p.2416-2423

2009

Volltextzugriff (PDF)

Risk of superficial squamous cell carcinoma developing in the head and neck region in patients with esophageal squamous cell carcinoma

The Laryngoscope, 2012-06, Vol.122 (6), p.1291-1296

2012

Volltextzugriff (PDF)

Promoter DNA methylation of CDO1 gene and its clinical significance in esophageal squamous cell carcinoma

Diseases of the esophagus, 2017-02, Vol.30 (2), p.1-9

2017

Volltextzugriff (PDF)

Neutrophil/lymphocyte ratio has a prognostic value for patients with terminal cancer

World journal of surgical oncology, 2016-05, Vol.14 (146), p.148-148, Article 148

2016

Volltextzugriff (PDF)

Multimodality Treatment and Prognosis in Esophageal Squamous Cell Carcinoma Requiring Esophagectomy

Hepato-gastroenterology, 2014-06, Vol.61 (132), p.1042

2014

Volltextzugriff (PDF)

Identification of EGFR expression status association with metastatic lymph node density (ND) by expression microarray analysis of advanced gastric cancer

Cancer medicine (Malden, MA), 2015-01, Vol.4 (1), p.90-100

2015

Volltextzugriff (PDF)

Phosphatase of regenerating liver-3 as a prognostic biomarker in histologically node-negative gastric cancer

Oncology reports, 2009-06, Vol.21 (6), p.1467-1475

2009

Volltextzugriff (PDF)

Lymph Node Metastasis Density (ND)-factor Association with Malignant Degree and ND40 as Non-curative Factor in Gastric Cancer

Anticancer research, 2008, Vol.28 (1B), p.435-441

2008

Volltextzugriff (PDF)

First drainage lymph node(s) in gastric cancer: analysis of the topographical pattern of lymph node metastasis in patients with pN-1 stage tumors

Anticancer research, 2003-01, Vol.23 (1B), p.601

2003

Volltextzugriff (PDF)

Surgical outcome of node-positive early gastric cancer with particular reference to nodal status

Anticancer research, 2000-09, Vol.20 (5C), p.3695

2000

Volltextzugriff (PDF)

Which patients with advanced, proximal gastric cancer benefit from complete clearance of spleno-pancreatic lymph nodes?

Anticancer research, 2002-11, Vol.22 (6B), p.3513

2002

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Aktive Filter

Nur zeigenMit Volltextzugriff

ThemaMale

ThemaNeoplasm Staging

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

13 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Definitive Chemoradiation Therapy With Docetaxel, Cisplatin, and 5-Fluorouracil (DCF-R) in Advanced Esophageal Cancer: A Phase 2 Trial (KDOG 0501-P2)

Prognostic impact of venous invasion in stage IB node-negative gastric cancer

Prognostic Advantage of Docetaxel/Cisplatin/ 5-Fluorouracil Neoadjuvant Chemotherapy in Clinical Stage II/III Esophageal Squamous Cell Carcinoma due to Excellent Control of Preoperative Disease and Postoperative Lymph Node Recurrence

Survival outcome of laparoscopic gastrectomy for clinical early (cT1) gastric cancer

Conversion surgery after combination chemotherapy of docetaxel, cisplatin and S-1 (DCS) for far-advanced gastric cancer

Long-term prognostic outcome of cT1 gastric cancer patients who underwent laparoscopic gastrectomy after 5-year follow-up

Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer

Lymph node ratio is a critical prognostic predictor in gastric cancer treated with S-1 chemotherapy

Lymphatic Tumor Emboli Detected by D2-40 Immunostaining Can More Accurately Predict Lymph-node Metastasis

Preoperative tumor size is a critical prognostic factor for patients with Borrmann type III gastric cancer

Clinical Significance of Total Gastrectomy for Proximal Gastric Cancer

A Multi-institutional, Prospective, Phase II Feasibility Study of Laparoscopy-Assisted Distal Gastrectomy with D2 Lymph Node Dissection for Locally Advanced Gastric Cancer (JLSSG0901)

Surgical Resection of Stage IV Gastric Cancer and Prognosis

Survival after surgical treatment of early gastric cancer: surgical techniques and long-term survival

Laparoscopy-assisted pancreas- and spleen-preserving total gastrectomy for gastric cancer as compared with open total gastrectomy

Risk of superficial squamous cell carcinoma developing in the head and neck region in patients with esophageal squamous cell carcinoma

Promoter DNA methylation of CDO1 gene and its clinical significance in esophageal squamous cell carcinoma

Neutrophil/lymphocyte ratio has a prognostic value for patients with terminal cancer

Multimodality Treatment and Prognosis in Esophageal Squamous Cell Carcinoma Requiring Esophagectomy

Identification of EGFR expression status association with metastatic lymph node density (ND) by expression microarray analysis of advanced gastric cancer

Phosphatase of regenerating liver-3 as a prognostic biomarker in histologically node-negative gastric cancer

Lymph Node Metastasis Density (ND)-factor Association with Malignant Degree and ND40 as Non-curative Factor in Gastric Cancer

First drainage lymph node(s) in gastric cancer: analysis of the topographical pattern of lymph node metastasis in patients with pN-1 stage tumors

Surgical outcome of node-positive early gastric cancer with particular reference to nodal status

Which patients with advanced, proximal gastric cancer benefit from complete clearance of spleno-pancreatic lymph nodes?

Aktive Filter

Suchergebnisse filtern